233 related articles for article (PubMed ID: 1707709)
1. The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO-donors.
Salvemini D; Radziszewski W; Korbut R; Vane J
Br J Pharmacol; 1990 Dec; 101(4):991-5. PubMed ID: 1707709
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide from vascular smooth muscle cells: regulation of platelet reactivity and smooth muscle cell guanylate cyclase.
Mollace V; Salvemini D; Anggard E; Vane J
Br J Pharmacol; 1991 Nov; 104(3):633-8. PubMed ID: 1724627
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide donors induce extrusion of cyclic GMP from isolated human blood platelets by a mechanism which may be modulated by prostaglandins.
Radziszewski W; Chopra M; Zembowicz A; Gryglewski R; Ignarro LJ; Chaudhuri G
Int J Cardiol; 1995 Oct; 51(3):211-20. PubMed ID: 8586470
[TBL] [Abstract][Full Text] [Related]
5. LY 83583 (6-anilino-5,8-quinolinedione) blocks nitrovasodilator-induced cyclic GMP increases and inhibition of platelet activation.
Mülsch A; Lückhoff A; Pohl U; Busse R; Bassenge E
Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):119-25. PubMed ID: 2552329
[TBL] [Abstract][Full Text] [Related]
6. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
Fisch A; Michael-Hepp J; Meyer J; Darius H
Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414
[TBL] [Abstract][Full Text] [Related]
7. CHF 2206, a new potent vasodilating and antiaggregating drug as potential nitric oxide donor.
Civelli M; Caruso P; Giossi M; Bergamaschi M; Razzetti R; Bongrani S; Gasco A
Eur J Pharmacol; 1994 Apr; 255(1-3):17-24. PubMed ID: 7517880
[TBL] [Abstract][Full Text] [Related]
8. Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.
Negrescu EV; Grünberg B; Kratzer MA; Lorenz R; Siess W
Cardiovasc Drugs Ther; 1995 Aug; 9(4):619-29. PubMed ID: 8547213
[TBL] [Abstract][Full Text] [Related]
9. Conversion of glyceryl trinitrate to nitric oxide in tolerant and non-tolerant smooth muscle and endothelial cells.
Salvemini D; Pistelli A; Vane J
Br J Pharmacol; 1993 Jan; 108(1):162-9. PubMed ID: 8381319
[TBL] [Abstract][Full Text] [Related]
10. Vascular and anti-platelet actions of 1,2- and 1,3-glyceryl dinitrate.
Salvemini D; Pistelli A; Anggard E
Br J Pharmacol; 1993 Nov; 110(3):937-42. PubMed ID: 8298817
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
Gordge MP; Hothersall JS; Noronha-Dutra AA
Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
[TBL] [Abstract][Full Text] [Related]
12. Synergism between nitric oxide and hydrogen peroxide in the inhibition of platelet function: the roles of soluble guanylyl cyclase and vasodilator-stimulated phosphoprotein.
Sabetkar M; Naseem KM; Tullett JM; Friebe A; Koesling D; Bruckdorfer KR
Nitric Oxide; 2001 Jun; 5(3):233-42. PubMed ID: 11384196
[TBL] [Abstract][Full Text] [Related]
13. Cyclic AMP and cyclic GMP phosphodiesterase inhibition by an antiplatelet agent, 6-[(3-methylene-2-oxo-5-phenyl-5-tetrahydrofuranyl)methoxy)quinol inone (CCT-62).
Liao CH; Tzeng CC; Teng CM
Eur J Pharmacol; 1998 May; 349(1):107-14. PubMed ID: 9669503
[TBL] [Abstract][Full Text] [Related]
14. Insulin increases guanosine-3',5'-cyclic monophosphate in human platelets. A mechanism involved in the insulin anti-aggregating effect.
Trovati M; Massucco P; Mattiello L; Mularoni E; Cavalot F; Anfossi G
Diabetes; 1994 Aug; 43(8):1015-9. PubMed ID: 7518780
[TBL] [Abstract][Full Text] [Related]
15. Effect of some cyclooxygenase inhibitors on the increase in guanosine 3':5'-cyclic monophosphate induced by NO-donors in human whole platelets.
Failli P; Cecchi E; Tosti-Guerra C; Mugelli A; Laffi G; Zilletti L; Giotti A
Br J Pharmacol; 1998 Apr; 123(7):1457-63. PubMed ID: 9579743
[TBL] [Abstract][Full Text] [Related]
16. Aged Garlic Extract Inhibits Human Platelet Aggregation by Altering Intracellular Signaling and Platelet Shape Change.
Rahman K; Lowe GM; Smith S
J Nutr; 2016 Feb; 146(2):410S-415S. PubMed ID: 26764324
[TBL] [Abstract][Full Text] [Related]
17. Exogenous GTP increases cyclic GMP and inhibits thrombin-induced aggregation of washed human platelets: comparison with ATP, adenosine and guanosine.
Vuorinen P; Laustiola KE
Pharmacol Toxicol; 1992 Oct; 71(4):289-93. PubMed ID: 1333596
[TBL] [Abstract][Full Text] [Related]
18. Involvement of platelet cyclic GMP but not cyclic AMP suppression in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro.
Hirafuji M; Nezu A; Shinoda H; Minami M
Br J Pharmacol; 1996 Jan; 117(2):299-304. PubMed ID: 8789382
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the pharmacological actions of nitrovasodilators by methylene blue and pyocyanin.
Gryglewski RJ; Zembowicz A; Salvemini D; Taylor GW; Vane JR
Br J Pharmacol; 1992 Aug; 106(4):838-45. PubMed ID: 1327388
[TBL] [Abstract][Full Text] [Related]
20. Nitrovasodilators and cGMP inhibit human platelet activation.
Doni MG; Alexandre A; Padoin E; Bertoncello S; Deana R
Cardioscience; 1991 Sep; 2(3):161-5. PubMed ID: 1660321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
